Advanced non-small cell lung cancer (NSCLC) continues to be an incurable family of
thoracic malignancies that is chronically managed with chemotherapy, targeted therapy, and …

Lung cancer being the most prevalent malignancy in men and the 3 rd most frequent in
women is still associated with dismal prognosis due to advanced disease at the time of …

The epithelial-mesenchymal transition (EMT) is an important factor in lung cancer
metastasis, and targeting EMT is a potential therapeutic strategy. Fucosyltransferase IV …

Cisplatin is a first line chemotherapy in lung cancer, but decreased susceptibility may limit its
application. In solid tumors, hypoxia alters the microenvironment and is associated with …

Cancer is one of the most serious malignant diseases, and chemotherapy is cancer's main
clinical treatment method. However, chemotherapy inevitably produces drug resistance, and …

Background Sulforaphane (SFN), an isothiocyanate isolated from broccoli, has been
reported to have chemopreventive activity. However, the effects of SFN on lung cancer have …

The annual global mortality rate of cancer has increased dramatically. Although various
therapies are used for cancer, the results have not been satisfactory. Chemotherapy is …

Objective To investigate the effects of bisdemethoxycurcumin (BDMC) on non-small cell lung
cancer (NSCLC) cell line, A549, and the highly metastatic lung cancer 95D cells. Methods …

Chemotherapy is a commonly used strategy for advanced lung cancer patients. However, its
clinical application is restrained due to its toxicity and drug resistance. Ginsenoside Rg3 …

Increased survival of cancer cells mediated by high levels of ionizing radiation (IR) reduces
the effectiveness of radiation therapy for non-small cell lung cancer (NSCLC). In the present …